863 related articles for article (PubMed ID: 30774631)
1. The Immunology of Macrophage Activation Syndrome.
Crayne CB; Albeituni S; Nichols KE; Cron RQ
Front Immunol; 2019; 10():119. PubMed ID: 30774631
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
Schulert GS; Grom AA
Annu Rev Med; 2015; 66():145-59. PubMed ID: 25386930
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Vandenhaute J; Wouters CH; Matthys P
Front Immunol; 2019; 10():3089. PubMed ID: 32010140
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
Karakike E; Giamarellos-Bourboulis EJ
Front Immunol; 2019; 10():55. PubMed ID: 30766533
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and correct diagnosis of macrophage activation syndrome.
Cron RQ; Davi S; Minoia F; Ravelli A
Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
[TBL] [Abstract][Full Text] [Related]
6. Genetic defects in cytolysis in macrophage activation syndrome.
Zhang M; Behrens EM; Atkinson TP; Shakoory B; Grom AA; Cron RQ
Curr Rheumatol Rep; 2014; 16(9):439. PubMed ID: 25086802
[TBL] [Abstract][Full Text] [Related]
7. Macrophage Activation Syndrome.
Sen ES; Clarke SL; Ramanan AV
Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
[TBL] [Abstract][Full Text] [Related]
8. The genetics of macrophage activation syndrome.
Schulert GS; Cron RQ
Genes Immun; 2020 May; 21(3):169-181. PubMed ID: 32291394
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome and cytokine-directed therapies.
Schulert GS; Grom AA
Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):277-92. PubMed ID: 24974063
[TBL] [Abstract][Full Text] [Related]
11. Convergent pathways of the hyperferritinemic syndromes.
Schulert GS; Canna SW
Int Immunol; 2018 Apr; 30(5):195-203. PubMed ID: 29420734
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
13. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
Henderson LA; Cron RQ
Paediatr Drugs; 2020 Feb; 22(1):29-44. PubMed ID: 31732958
[TBL] [Abstract][Full Text] [Related]
14. Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.
Wakiguchi H; Hasegawa S; Hirano R; Kaneyasu H; Wakabayashi-Takahara M; Ohga S
Pediatr Rheumatol Online J; 2015 Nov; 13():49. PubMed ID: 26581448
[TBL] [Abstract][Full Text] [Related]
15. Cytokine Storm Syndrome.
Cron RQ; Goyal G; Chatham WW
Annu Rev Med; 2023 Jan; 74():321-337. PubMed ID: 36228171
[TBL] [Abstract][Full Text] [Related]
16. Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.
Burn TN; Weaver L; Rood JE; Chu N; Bodansky A; Kreiger PA; Behrens EM
Arthritis Rheumatol; 2020 Feb; 72(2):335-347. PubMed ID: 31400073
[TBL] [Abstract][Full Text] [Related]
17. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Shimizu M
Immunol Med; 2021 Dec; 44(4):237-245. PubMed ID: 33982649
[TBL] [Abstract][Full Text] [Related]
19. Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.
Crayne C; Cron RQ
Eur J Rheumatol; 2020 Feb; 7(Suppl1):S13-S20. PubMed ID: 31804174
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.
Ravelli A; Grom AA; Behrens EM; Cron RQ
Genes Immun; 2012 Jun; 13(4):289-98. PubMed ID: 22418018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
